These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 15277612)

  • 1. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.
    DeCarli C; Mungas D; Harvey D; Reed B; Weiner M; Chui H; Jagust W
    Neurology; 2004 Jul; 63(2):220-7. PubMed ID: 15277612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
    Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.
    Korf ES; Wahlund LO; Visser PJ; Scheltens P
    Neurology; 2004 Jul; 63(1):94-100. PubMed ID: 15249617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease.
    Mungas D; Reed BR; Jagust WJ; DeCarli C; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
    Neurology; 2002 Sep; 59(6):867-73. PubMed ID: 12297568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
    Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
    Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer's disease.
    Lee YM; Park JM; Lee BD; Moon E; Chung YI; Kang CJ
    Dement Geriatr Cogn Disord; 2012; 33(4):240-4. PubMed ID: 22738930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment.
    Geroldi C; Rossi R; Calvagna C; Testa C; Bresciani L; Binetti G; Zanetti O; Frisoni GB
    J Neurol Neurosurg Psychiatry; 2006 Nov; 77(11):1219-22. PubMed ID: 16891386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up.
    Siuda J; Gorzkowska A; Patalong-Ogiewa M; Krzystanek E; Czech E; Wiechuła B; Garczorz W; Danch A; Jasińska-Myga B; Opala G
    Neurol Neurochir Pol; 2009; 43(4):321-9. PubMed ID: 19742390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of cognitive decline and rates of conversion to dementia in patients with degenerative and vascular forms of MCI.
    Marra C; Ferraccioli M; Vita MG; Quaranta D; Gainotti G
    Curr Alzheimer Res; 2011 Feb; 8(1):24-31. PubMed ID: 20704559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study.
    Amieva H; Letenneur L; Dartigues JF; Rouch-Leroyer I; Sourgen C; D'Alchée-Birée F; Dib M; Barberger-Gateau P; Orgogozo JM; Fabrigoule C
    Dement Geriatr Cogn Disord; 2004; 18(1):87-93. PubMed ID: 15087583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.
    Duara R; Loewenstein DA; Greig MT; Potter E; Barker W; Raj A; Schinka J; Borenstein A; Schoenberg M; Wu Y; Banko J; Potter H
    Am J Geriatr Psychiatry; 2011 Nov; 19(11):951-60. PubMed ID: 21422909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.
    Staekenborg SS; Koedam EL; Henneman WJ; Stokman P; Barkhof F; Scheltens P; van der Flier WM
    Stroke; 2009 Apr; 40(4):1269-74. PubMed ID: 19228848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment.
    Jessen F; Wiese B; Bachmann C; Eifflaender-Gorfer S; Haller F; Kölsch H; Luck T; Mösch E; van den Bussche H; Wagner M; Wollny A; Zimmermann T; Pentzek M; Riedel-Heller SG; Romberg HP; Weyerer S; Kaduszkiewicz H; Maier W; Bickel H;
    Arch Gen Psychiatry; 2010 Apr; 67(4):414-22. PubMed ID: 20368517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways.
    Maruyama M; Matsui T; Tanji H; Nemoto M; Tomita N; Ootsuki M; Arai H; Sasaki H
    Arch Neurol; 2004 May; 61(5):716-20. PubMed ID: 15148149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.
    Dickerson BC; Sperling RA; Hyman BT; Albert MS; Blacker D
    Arch Gen Psychiatry; 2007 Dec; 64(12):1443-50. PubMed ID: 18056553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal volumetric MRI change and rate of cognitive decline.
    Mungas D; Harvey D; Reed BR; Jagust WJ; DeCarli C; Beckett L; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
    Neurology; 2005 Aug; 65(4):565-71. PubMed ID: 16116117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular risk factors, incidence of MCI, and rates of progression to dementia.
    Solfrizzi V; Panza F; Colacicco AM; D'Introno A; Capurso C; Torres F; Grigoletto F; Maggi S; Del Parigi A; Reiman EM; Caselli RJ; Scafato E; Farchi G; Capurso A;
    Neurology; 2004 Nov; 63(10):1882-91. PubMed ID: 15557506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular risk factors and intensity of cognitive dysfunction in MCI.
    Siuda J; Gorzkowska A; Opala G; Ochudło S
    J Neurol Sci; 2007 Jun; 257(1-2):202-5. PubMed ID: 17335850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between mild parkinsonian signs and mild cognitive impairment in a community.
    Louis ED; Schupf N; Manly J; Marder K; Tang MX; Mayeux R
    Neurology; 2005 Apr; 64(7):1157-61. PubMed ID: 15824340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.